Ondansetron to Prevent Oral Rehydration Failure in Children With Cholera
Ondansetron to Prevent Oral Rehydration Failure in Children With Cholera
Not yet recruiting · NCT07795060 · Registry updated 2026-08-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ondansetron to Prevent Oral Rehydration Failure in Children With Cholera | Bacterial Infections and Mycoses, Dehydration, Infections, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting, Water-Electrolyte Imbalance, arthritic joint disease, arthropathy, bacterial infectious disease, cholera, gram-negative bacterial infections, metabolic disease, musculoskeletal system disorder, osteoarthritis, rheumatic disorder, vibrio infectious disease | Not yet recruiting | Phase 2 | 2026-08-31 | NCT07795060 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Public Interest Science Center | 1 |
| Thrasher Research Fund | 11 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospital of Brazzaville (UHB) - Cholera Treatment Unit | Brazzaville | Republic of the Congo | 1 |